David W. Boyer - Feb 4, 2022 Form 3 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Corp. Affairs Officer
Signature
/s/ David Boyer
Stock symbol
NBIX
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
3
Date filed
2/9/2022, 07:01 PM
Next filing
Feb 9, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBIX Common Stock 2.08K Feb 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NBIX Incentive Stock Option Feb 4, 2022 Common Stock 4.48K $89.23 Direct F1
holding NBIX Non-Qualified Stock Option Feb 4, 2022 Common Stock 43.7K $89.23 Direct F1
holding NBIX Incentive Stock Option Feb 4, 2022 Common Stock 479 $102.90 Direct F2
holding NBIX Non-Qualified Stock Option Feb 4, 2022 Common Stock 11K $102.90 Direct F2
holding NBIX Incentive Stock Option Feb 4, 2022 Common Stock 1.28K $117.63 Direct F3
holding NBIX Non-Qualified Stock Option Feb 4, 2022 Common Stock 33.8K $117.63 Direct F3
holding NBIX Incentive Stock Option Feb 4, 2022 Common Stock 1.19K $79.02 Direct F4
holding NBIX Non-Qualified Stock Option Feb 4, 2022 Common Stock 55.9K $79.02 Direct F4
holding NBIX Restricted Stock Unit Feb 4, 2022 Common Stock 10.9K Direct F5, F6
holding NBIX Restricted Stock Unit Feb 4, 2022 Common Stock 1.82K Direct F6, F7
holding NBIX Restricted Stock Unit Feb 4, 2022 Common Stock 5.31K Direct F6, F8
holding NBIX Restriced Stock Unit Feb 4, 2022 Common Stock 8.38K Direct F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted October 1, 2019 and vests at 25% upon first anniversary (October 1, 2020) and remaining 75% vesting in 36 equal monthly installments beginning November 1, 2020.
F2 Option granted February 6, 2020 and vests monthly over four years.
F3 Option granted February 8, 2021 and vests monthly over four years.
F4 Option granted January 31, 2022 and vests monthly over four years.
F5 1/4 of the Restricted Stock Units vested on October 1, 2020 and October 1, 2021. The remaining units vest equally on each of October 1, 2022, October 1, 2023.
F6 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F7 1/4th of the Restricted Stock Units vested on February 6, 2021. The remaining units vest equally on each of February 6, 2022, February 6, 2023, February 6, 2024.
F8 The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 8, 2022, February 8, 2023, February 8, 2024, and February 8, 2025.
F9 The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, January 26, 2026.